Laura M Enomoto1, Deepika P Shrestha2, Meredith B Rosenthal3, Christopher S Hollenbeak4, Robert A Gabbay5. 1. The Pennsylvania State University, College of Medicine, Department of Medicine, 500 University Drive, Hershey, PA 17033, USA. Electronic address: lenomoto@hmc.psu.edu. 2. The Pennsylvania State University, College of Medicine, Department of Medicine, 500 University Drive, Hershey, PA 17033, USA. Electronic address: dshrestha2@lghealth.org. 3. Harvard School of Public Health, Health Policy and Management, 677 Huntington Avenue, Boston, MA 02115, USA. Electronic address: mrosenth@hsph.harvard.edu. 4. The Pennsylvania State University, College of Medicine, Department of Medicine, 500 University Drive, Hershey, PA 17033, USA. Electronic address: chollenbeak@psu.edu. 5. Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA. Electronic address: robert.gabbay@joslin.harvard.edu.
Abstract
AIMS: Patients with type 2 diabetes mellitus (type 2 DM) are at greater risk of poor hospital outcomes. The purpose of this study was to determine the impact of type 2 DM on 30-day hospital readmission and length of stay (LOS). METHODS: We studied all inpatient admissions in Pennsylvania during 2011 using data from the Pennsylvania Health Care Cost Containment Council. Outcomes included 30-day readmission and inpatient LOS. We estimated the impact of type 2 DM on readmission and LOS, and identified risk factors for readmission and prolonged LOS. RESULTS: Among inpatient admissions, patients with diabetes were more likely to be readmitted (AOR=1.17, P<0.001) and have longer LOS (0.19days, P<0.001) compared to patients without diabetes. Among those with diabetes, several factors were associated with readmission, including demographics, source of admission, and comorbidities. Patients with diabetes were more likely to be readmitted for infectious complications (9.4% vs. 7.7%), heart failure (6.0% vs. 3.1%), and chest pain/MI (5.5% vs. 3.3%) than patients without diabetes. CONCLUSIONS: Diabetes is associated with risk of 30-day readmission and LOS, and several patient-specific factors are associated with outcomes for patients with diabetes. Future studies may target risk factors to develop strategies to reduce readmissions and LOS.
AIMS: Patients with type 2 diabetes mellitus (type 2 DM) are at greater risk of poor hospital outcomes. The purpose of this study was to determine the impact of type 2 DM on 30-day hospital readmission and length of stay (LOS). METHODS: We studied all inpatient admissions in Pennsylvania during 2011 using data from the Pennsylvania Health Care Cost Containment Council. Outcomes included 30-day readmission and inpatient LOS. We estimated the impact of type 2 DM on readmission and LOS, and identified risk factors for readmission and prolonged LOS. RESULTS: Among inpatient admissions, patients with diabetes were more likely to be readmitted (AOR=1.17, P<0.001) and have longer LOS (0.19days, P<0.001) compared to patients without diabetes. Among those with diabetes, several factors were associated with readmission, including demographics, source of admission, and comorbidities. Patients with diabetes were more likely to be readmitted for infectious complications (9.4% vs. 7.7%), heart failure (6.0% vs. 3.1%), and chest pain/MI (5.5% vs. 3.3%) than patients without diabetes. CONCLUSIONS:Diabetes is associated with risk of 30-day readmission and LOS, and several patient-specific factors are associated with outcomes for patients with diabetes. Future studies may target risk factors to develop strategies to reduce readmissions and LOS.
Authors: Elias K Spanakis; Guillermo E Umpierrez; Tariq Siddiqui; Min Zhan; Soren Snitker; Jeffrey C Fink; John D Sorkin Journal: J Clin Endocrinol Metab Date: 2019-09-01 Impact factor: 5.958
Authors: Vivek Bansal; Adham Mottalib; Taranveer K Pawar; Noormuhammad Abbasakoor; Eunice Chuang; Abrar Chaudhry; Mahmoud Sakr; Robert A Gabbay; Osama Hamdy Journal: BMJ Open Diabetes Res Care Date: 2018-04-05
Authors: Andrew P Demidowich; Kristine Batty; Teresa Love; Sam Sokolinsky; Lisa Grubb; Catherine Miller; Larry Raymond; Jeanette Nazarian; M Shafeeq Ahmed; Leo Rotello; Mihail Zilbermint Journal: J Diabetes Sci Technol Date: 2021-02-20
Authors: Jamie M Smith; Haiqun Lin; Charlotte Thomas-Hawkins; Jennifer Tsui; Olga F Jarrín Journal: Int J Environ Res Public Health Date: 2021-05-25 Impact factor: 3.390
Authors: Michelle Quarti Machado Rosa; Roger Dos Santos Rosa; Marcelo G Correia; Denizar V Araujo; Luciana R Bahia; Cristiana M Toscano Journal: Int J Environ Res Public Health Date: 2018-02-08 Impact factor: 3.390
Authors: Elias K Spanakis; Lakshmi G Singh; Tariq Siddiqui; John D Sorkin; George Notas; Michelle F Magee; Jeffrey C Fink; Min Zhan; Guillermo E Umpierrez Journal: BMJ Open Diabetes Res Care Date: 2020-05